Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma

Activating epidermal growth factor receptor (EGFR) mutations in metastatic non-small cell lung cancer (NSCLC) are associated with a high response rate to EGFR tyrosine kinase inhibitor (TKI). The current guidelines recommend routine EGFR mutational analysis prior to initiating first line systemic th...

Full description

Bibliographic Details
Main Authors: Michelle Levy, Liisa Lyon, Erika Barbero, John Wong, Jennifer Marie Suga, Danny Sam, Minggui Pan
Format: Article
Language:English
Published: MDPI AG 2017-12-01
Series:Medical Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3271/5/4/34